SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-23-000071
Filing Date
2023-08-10
Accepted
2023-08-10 16:12:16
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20230630.htm   iXBRL 10-Q 1190737
2 EX-10.1 greensteinleo2023-05x03sep.htm EX-10.1 159863
3 EX-10.2 exhibit102-tarsusformofs.htm EX-10.2 22962
4 EX-31.1 exhibit311-63023.htm EX-31.1 12692
5 EX-31.2 exhibit312-63023.htm EX-31.2 12950
6 EX-32.1 exhibit321-63023.htm EX-32.1 9883
7 EX-32.2 exhibit322-63023.htm EX-32.2 9685
13 GRAPHIC exhibit102-tarsusformofs001.jpg GRAPHIC 227961
14 exhibit102-tarsusformofs002.jpg GRAPHIC 309277
15 exhibit102-tarsusformofs003.jpg GRAPHIC 310142
16 exhibit102-tarsusformofs004.jpg GRAPHIC 235819
17 exhibit102-tarsusformofs005.jpg GRAPHIC 235243
18 exhibit102-tarsusformofs006.jpg GRAPHIC 225058
19 exhibit102-tarsusformofs007.jpg GRAPHIC 48426
  Complete submission text file 0001819790-23-000071.txt   8993561

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20230630.xsd EX-101.SCH 43157
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20230630_cal.xml EX-101.CAL 69331
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20230630_def.xml EX-101.DEF 190373
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20230630_lab.xml EX-101.LAB 578784
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20230630_pre.xml EX-101.PRE 373367
73 EXTRACTED XBRL INSTANCE DOCUMENT tars-20230630_htm.xml XML 987174
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 231159496
SIC: 2836 Biological Products, (No Diagnostic Substances)